Related Experiment Video
Updated: Jun 19, 2025

Combined Conditional Knockdown and Adapted Sphere Formation Assay to Study a Stemness-Associated Gene of Patient-derived Gastric Cancer Stem Cells
Published on: May 9, 2020
PGRMC1 promotes NSCLC stemness phenotypes by disrupting TRIM56-mediated ubiquitination of AHR
Anqi Guan1, Ziyu Dai2, Chen Jiang2
1Department of Geriatrics, Xiangya Hospital, Central South University, Changsha 410008, China; Xiangya Lung Cancer Center, Xiangya Hospital, Central South University, Changsha 410008, China.
Abstract:
Cancer stem cells (CSCs) are responsible for tumor chemoresistance, and the aryl hydrocarbon receptor (AHR) is indispensable for maintaining CSC characteristics. Here, we aimed to investigate how the interaction between progesterone receptor membrane component 1 (PGRMC1) and AHR contributes to the maintenance of CSC phenotypes in non-small cell lung cancer (NSCLC). Clinical data and tissue microarray analyses indicated that patients with elevated PGRMC1 expression had poorer prognoses. Moreover, PGRMC1 overexpression enhanced CSC phenotypes and chemotherapy resistance in vitro and in vivo by modulating AHR ubiquitination. We then determined the specific interaction sites between PGRMC1 and AHR. Mass spectrometry screening identified tripartite motif containing 56 (TRIM56) as the E3 ligase targeting AHR. Notably, PGRMC1 overexpression inhibited the interaction between TRIM56 and AHR. Overall, our study revealed a regulatory mechanism that involves PGRMC1, AHR, and TRIM56, providing insights for developing CSC-targeting strategies in NSCLC treatment.
Insights
Progesterone receptor membrane component 1 (PGRMC1) drives cancer stem cell (CSC) traits and chemoresistance in non-small cell lung cancer (NSCLC) by inhibiting AHR ubiquitination. This reveals a new therapeutic target for NSCLC.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Cancer stem cells (CSCs) drive tumor chemoresistance and recurrence.
- The aryl hydrocarbon receptor (AHR) is crucial for maintaining CSC properties.
- Non-small cell lung cancer (NSCLC) remains a leading cause of cancer mortality.
Purpose of the Study:
- To elucidate the role of progesterone receptor membrane component 1 (PGRMC1) in regulating AHR and CSC phenotypes in NSCLC.
- To investigate the interaction between PGRMC1, AHR, and E3 ligase TRIM56 in NSCLC.
- To identify potential therapeutic targets for overcoming CSC-mediated chemoresistance in NSCLC.
Main Methods:
- Analysis of clinical data and tissue microarrays from NSCLC patients.
- In vitro and in vivo experiments assessing CSC phenotypes and chemotherapy resistance.
- Mass spectrometry to identify protein interactions and E3 ligases.
- Investigation of protein ubiquitination and interaction modulation.
Main Results:
- Elevated PGRMC1 expression correlates with poorer prognosis in NSCLC patients.
- PGRMC1 overexpression enhances CSC phenotypes and chemotherapy resistance.
- PGRMC1 modulates AHR ubiquitination by inhibiting the interaction between AHR and TRIM56.
- Specific interaction sites between PGRMC1 and AHR were identified.
Conclusions:
- A novel regulatory axis involving PGRMC1, AHR, and TRIM56 is identified in NSCLC.
- PGRMC1 promotes CSC characteristics and chemoresistance by interfering with AHR ubiquitination via TRIM56.
- Targeting this PGRMC1-AHR-TRIM56 pathway offers a potential strategy for NSCLC treatment.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Restarting Stalled Replication Forks
DNA Damage can Stall the Cell Cycle

